Corporate Strategy and Investment

The Corporate Strategy and Investment team at Hyku Biosciences is responsible for identifying and evaluating strategic partnerships and investment opportunities that align with the company's mission to enhance patient outcomes. This team conducts in-depth market analysis, fosters relationships with potential collaborators, and supports the development of long-term growth strategies to advance innovative therapies in precise covalent targeting.